- Report
- May 2024
- 182 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- May 2024
- 185 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- April 2024
- 180 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- April 2024
- 188 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- April 2024
- 190 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- February 2024
- 185 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- January 2024
- 185 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- January 2024
- 189 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- July 2024
- 100 Pages
Global
From €2594EUR$2,625USD£2,159GBP
€3705EUR$3,750USD£3,084GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
- Report
- June 2024
- 200 Pages
Global
From €5499EUR$5,565USD£4,577GBP
€7855EUR$7,950USD£6,538GBP
- Report
- May 2024
- 160 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- September 2024
- 179 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- August 2024
- 184 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- August 2024
- 169 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- July 2024
- 138 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- June 2024
- 171 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- June 2024
- 162 Pages
Global
From €2470EUR$2,500USD£2,056GBP
The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more